Literature DB >> 8633486

A review of immune modifier therapy for inflammatory bowel disease: azathioprine, 6-mercaptopurine, cyclosporine, and methotrexate.

W J Sandborn1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8633486

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


× No keyword cloud information.
  48 in total

1.  Refractory Inflammatory Bowel Disease.

Authors:  Thomas A. Judge; Gary R. Lichtenstein
Journal:  Curr Treat Options Gastroenterol       Date:  2001-06

2.  Increased incidence of non-Hodgkin's lymphoma in inflammatory bowel disease patients on immunosuppressive therapy but overall risk is low.

Authors:  R J Farrell; Y Ang; P Kileen; D S O'Briain; D Kelleher; P W Keeling; D G Weir
Journal:  Gut       Date:  2000-10       Impact factor: 23.059

Review 3.  Optimizing 6-mercaptopurine and azathioprine therapy in the management of inflammatory bowel disease.

Authors:  Kara Bradford; David Q Shih
Journal:  World J Gastroenterol       Date:  2011-10-07       Impact factor: 5.742

Review 4.  Practical guidelines for the treatment of inflammatory bowel disease.

Authors:  T Kuhbacher; U R Fölsch
Journal:  World J Gastroenterol       Date:  2007-02-28       Impact factor: 5.742

5.  Thiopurines in inflammatory bowel disease: new strategies for optimization of pharmacotherapy?

Authors:  Luc J J Derijks; Daniel W Hommes
Journal:  Curr Gastroenterol Rep       Date:  2006-04

6.  Azathioprine and 6-mercaptopurine for maintenance of surgically-induced remission in Crohn's disease.

Authors:  Teuta Gjuladin-Hellon; Zipporah Iheozor-Ejiofor; Morris Gordon; Anthony K Akobeng
Journal:  Cochrane Database Syst Rev       Date:  2019-08-06

7.  Medical management of Crohn's disease.

Authors:  Paul A Feldman; Daniel Wolfson; Jamie S Barkin
Journal:  Clin Colon Rectal Surg       Date:  2007-11

Review 8.  Emerging opportunities for site-specific molecular and cellular interventions in autoimmune hepatitis.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2010-01-27       Impact factor: 3.199

9.  The effect of tacrolimus (FK-506) on Japanese patients with refractory Crohn's disease.

Authors:  Hiroyuki Tamaki; Hiroshi Nakase; Minoru Matsuura; Satoko Inoue; Sakae Mikami; Satoru Ueno; Norimitsu Uza; Hiroshi Kitamura; Katsuhiro Kasahara; Tsutomu Chiba
Journal:  J Gastroenterol       Date:  2008-10-29       Impact factor: 7.527

Review 10.  Ulcerative colitis has an aggressive course after orthotopic liver transplantation for primary sclerosing cholangitis.

Authors:  G V Papatheodoridis; M Hamilton; P K Mistry; B Davidson; K Rolles; A K Burroughs
Journal:  Gut       Date:  1998-11       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.